Holly Keyt, MD
Critical Care Medicine · San Antonio, TXNPI 1699902965
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Insmed, Inc. accounts for 91.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $10,641 and has fallen 96.6% since, to $358 in 2025. Among critical care medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $188.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$13K
- Vertex$263
- Gilead$223
- Chiesi USA, Inc.$151
- Astellas Pharma US Inc$145
- Olympus America Inc.$135
- plus $330 from 8 others
Across 4 payments — averaging $7606.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$30K
What the payments were for
- Consulting fees$2,70019%
- Speaking & faculty fees$8,32559%
- Travel & lodging$1,2028%
- Food & beverage$1,81713%
- Education$210%
- Gifts$711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 21 | $12,890 |
| Vertex | 8 | $263 |
| Gilead | 13 | $223 |
| Chiesi USA, Inc. | 6 | $151 |
| Astellas Pharma US Inc | 2 | $145 |
| Olympus America Inc. | 11 | $135 |
| AbbVie | 6 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Atricure, Inc. | 1 | $24 |
| Advanced Respiratory, Inc | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Philips North America LLC | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,137 in reported general payments places this provider in the 90th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrevymisLetermovir | 28 | $187,642 |
| Posaconazole | 16 | $20,292 |
| Atovaquone | 27 | $13,056 |
| Valganciclovir Hcl | 45 | $11,414 |
| Tacrolimus | 63 | $5,233 |
| Amphotericin B Liposome | 12 | $2,535 |
| Prednisone | 27 | $596 |
| Acyclovir | 24 | $214 |
| Pantoprazole Sodium | 41 | $198 |
| Famotidine | 14 | $188 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 36 | $162 |
| Rosuvastatin Calcium | 16 | $55 |
| Metoprolol Tartrate | 14 | $30 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in San Antonio
- Rachel GarvinSan Antonio$97K
- Adam GottulaSan Antonio$26K
- Scott HagedornSan Antonio$13K
- Patrick CullinanSan Antonio$9K
- Phillip MasonSan Antonio$9K
- Steven DavidoffPlano$364K
- William BartekAustin$284K
- Edwin ParsleyHouston$283K
- Hector PayanEl Paso$245K
- Bindu AkkantiHouston$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.